Loading...

BALAXI Balaxi Pharmaceuticals Ltd Other Situations Announcement

Blx

BLX

Balaxi Pharmaceuticals Ltd

(BALAXI)

2025 Announcement

Show Summary

Show Summary

Investor Presentation

Newspaper Publication

Disclosure Submission

Disclosure Submitted

Funds Utilization Update

Financial Results & Update

Re-appointment of Auditors

Secretarial Auditor Appoint...

Financial Results Submitted

SEBI Compliance Certificate

Trading Window Closure

Voting Results Submitted

Price Movement Clarification

Financial Results Submitted

Newspaper Publication

Postal Ballot Notice

Investor Presentation

Newspaper Publication

Integrated Filing Update

No Fund Deviation

Regulatory Fine Notice

Board Meeting Outcome

Financial Results Submitted

SEBI Compliance Certificate

Trading Window Closure

Credit Rating Update

Investor Presentation

Voting Results Submitted

Financial Results Published

Fund Utilization Status

Management Change

Management Change

Board Meeting Outcome

Financial Results Report

SEBI Compliance Certificate

Postal Ballot Notice

Postal Ballot Notice

Trading Window Closure

Director Appointment

AGM Voting Results

AGM Proceedings

Investor Presentation

Newspaper Publication

Deviations in fund utilization

Board Meeting Outcome

Financial Results & Investm...

Advertisement Publication

Business Report Submission

Newspaper Advertisement

Certificate Submission

Trading Window Closure

Business Expansion

Investor Presentation

Newspaper Advertisement

Funds Utilization Deviation

Board Meeting Outcome

Financial Results Submission

Record Date Notice

Record Date Announcement

Change in Officer

Resignation of Director

Management Change

Disclosure Submission

Voting Results Submission

Disclosure Submission

Certificate Submission

Allotment of Equity Shares

Equity Shares Allotment

Notice of Postal Ballot

Notice of Postal Ballot

Equity Shares Allotment

Clarification on Financial ...

Equity Shares Sub-Division ...

Share Subdivision Approval

Subdivision Approval

Equity Shares Allotted

Formation of Step-Down Subs...

Financial Results

Outcome of Board Meeting

Financial Results Publication

Investor Presentation

Deviation statement

Update on Pharmaceutical Fo...

Financial Results and Plant...

Board Meeting Outcome

Board Meeting Outcome

Conversion of Warrants into...

Certificate under Regulatio...

Trading Window Closure

Credit Rating Reaffirmation

Certificate Submission

Re-appointment of Independe...

Trading Window Closure

Disclosure under SEBI Takeo...

Re-appointment of Statutory...

Re-appointment of Auditors ...

Investor Presentation

Investor Presentation

Statement of Deviation

Statement of Deviation

Financial Results and Acqui...

Outcome of Board Meeting

Acquisition Approval

Financial Results and Acqui...

Financial Results & Acquisi...

Acquisition and Financial R...

Business Responsibility and...

External Links:

Data:

Balaxi Pharmaceuticals Limited reported no deviation in the utilization of funds raised through a preferential issue totaling ₹47,56,92,250 as of March 31, 2025.

AI Assistant

Balaxi Pharmaceuticals Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.